期刊文献+

环氧合酶-2在胃癌中的表达及预后意义 被引量:6

Expression of Cyclooxygenase-2 and Prognostic Signficance in Human Gastric Carcinoma
暂未订购
导出
摘要 目的:研究环氧合酶-2(COC-2)在胃癌、不典型增生及慢性萎缩性胃炎中的表达情况,探讨COX-2表达的预后意义。方法经手术病理证实的早、中期胃癌281例,进行预后随访调查。232例进行免疫组织化学染色。检则COX-2在胃癌及非癌组织中的表达情况,分析其与预后的关系。结果:早期胃癌的5年生存率为93.4%,中期胃癌的5年生存率为59.0%。COX-2在慢性萎缩性胃炎中的表达明显低于不典型增生者(P<0.01),在癌组织中的表达明显高于非癌组织(P<0.05~0.01);COX-2与胃癌淋巴结转移、血管浸润均密切相关(P<0.01);COX-2阳性表达者5年生存率明显低于阴性者(P<0.01)。结论:COX-2在胃癌组织呈过度表达状态,与胃癌的生长和浸润转移关系密切,可以作为反映胃癌生物学行为和判断预后的有效指标。 Purpose: To investigate the expression of cydooxygenasel-2(COX-2), in chronic atrophic gastritis, gastric mucosa! atypical hyperplasia, early and middle stage of gastric carcinoma, to identify the prognotic significance of COX-2 expression. Methods: 281 patients with early and middle stage of gastric carcinoma who underwent surgical resection were followed up. Expression of COX-2 was examined by immunohistocheinistry in 232 archival paraf-fmembedded tissue specimens and control groups. Results; 5-years sinvival rates of early and middle stage of gastric carcinoma were 93.4% and 59.0% , respectively. Expression of COX-2 was significantly higher in mucosal atypical hyperplasia than that in chronic atrophic gastritis (P < 0.01) . Compared with paired noncancerous specimens, COX - 2 levels in carcinoma tissue were significantly higher (/*<().05 ~0.01). Expression of COX-2 was highly correlated with lymph node metastasis and vascular invasion (P< 0.01). 'llie 5-years sumval rate in the patients with COX-2 expression was much lower than the rate in those patiants without CXO-2 expression(P < 0.01} Conclusion; Overexpression of COX-2 in patients with gastric carcinoma can enhance the possibility of invasion anil metastasis, implicating a poor prognosis. It may serve as the fairly good prognosic factors to indicate biologic behavior anil prognosis in gastric carcinoma.
出处 《临床消化病杂志》 2003年第1期3-6,共4页 Chinese Journal of Clinical Gastroenterology
关键词 环氧合酶-2 胃癌 预后 不典型增生型胃炎 慢性萎缩性胃炎 Gastric: neoplasm Cycl ooxygenase-2 Prognosis
  • 相关文献

参考文献7

  • 1Levy GN.Prostaglandin H synthases nonsteroidal anti-inflammatory drugs and colon cancer FASEB J,1997.
  • 2陆红,戈之铮,刘文忠,陈晓宇,彭延申,萧树东.环氧合酶-2蛋白在结肠疾病中的表达[J].胃肠病学,2000,5(3):158-160. 被引量:38
  • 3Shiraishi N;Inomata M;Osawa N.Early and late recurrence after gastrectomy for gastric carcinoma[J],2000(02).
  • 4Theuer CP;Kurosaki T;Ziogas A.Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific surival rates[J],2000(09).
  • 5Ohno R;YOSHINAGA K;FUJITA T.Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma[J],2001(10).
  • 6Murata H;Kawano S;Tsuji S.Cycooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carinoma,1999(02).
  • 7Chen CN;Sung CT;Lin MT.Clinicopathologic association of cyclooxygenase 1 and cyclooxygenase 2 expression in gastric adenocarcinoma[J],2001.

二级参考文献14

  • 1Williams CS, DuBois RN.Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol,1996, 270 (3 Pt 1):G393~400.
  • 2Giardiello FM, Offerhaus GJ, DuBois RN. The role of nonsteroidal anti-inflammatorydrugs in colorectal cancer prevention. Eur J Cancer, 1995,31A: 1071~1076.
  • 3Cohn SM, Schloemann S, Tessner T, Seibert K,Stenson WF. Crypt stem cell survival inthe mouse intestinal epithelium is regulated by prostaglandins synthesized throughcyclooxygenase-1.J Clin Invest, 1997, 99: 1367~1379.
  • 4Eberhart CE, Dubois RN. Eicosanoids and the gastrointestinal tract.Gastroenterology, 1995, 109:285~301.
  • 5Singer Ⅱ, Kawka DW, Schloemann S, Tessner T,Riehl T, Stenson WF. Cyclooxygenase 2is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology,1998, 115: 297~306.
  • 6Sharon P, Stenson WF. Enhanced synthesis of leukotriene B4 by colonic mucosa ininflammatory bowel disease. Gastroenterology, 1984, 86:453 ~460.
  • 7Masferrer JL, Reddy ST, Zweifel BS, Seibert K,Needleman P, Gilbert RS, HerschmanHR. In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 inperitoneal macrophages. J Pharmacol Exp Ther, 1994, 270: 1340~1344.
  • 8Izutani R, Loh EY, Reinecker H, et al. Increased expression of interleukin-8 mRNAin ulcerative colitis and Crohn's disease mucosa and epithelial cell. Inflammatory BowelDis, 1995, 1: 37~47.
  • 9Reuter BK, Asfaha S, Buret A, Sharkey KA,Wallace JL. Exacerbation ofinflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. JClin Invest, 1996, 98:2076~2085.
  • 10Oshima M, Dinchuk JE, Kargman SL, Oshima H,Hancock B, Kwong E, Trzaskos JM, EvansJF,Taketo MM. Suppression of intestinal polyposis in Apc delta716 knockout mice byinhibition of cyclooxygenase 2 (COX-2). Cell, 1996, 87: 803~809.

共引文献39

同被引文献44

  • 1Jian Cheng,Xiao-Ming Fan.Role of cyclooxygenase-2 in gastric cancer development and progression[J].World Journal of Gastroenterology,2013,19(42):7361-7368. 被引量:34
  • 2李唯,田生鸿.抗原联接技术在前列腺素与肺癌关系研究中的应用[J].武汉医学杂志,1989,13(3):107-108. 被引量:1
  • 3无,房静远(整理),刘文忠(整理),施尧(整理),戈之铮(整理),萧树东(整理).中国慢性胃炎共识意见(下)(2006,上海)[J].中华消化杂志,2007,27(2):118-120. 被引量:34
  • 4DANNHARDT G, KIEFER W.Cyclooxygenase inhibitors current stares and future prospects [J].Eur J Med Chem,2001,36(2):109.
  • 5Zhang F, Warskwlat V, Wettstein M ,et al.Hyperosmolarity Stimulates prostaglandin synthesis and cyclooxygenase22 expression in activated rat liver macrophages[J].Biochem J, 1995,312(Pt 1): 135.
  • 6Neil 1G P,Ford-Hutchinson A W.Expression of mRNA forcy-Clooxygenase--1 and cyclooxygenase-2 in human tissues[J].FEBS Lett, 1993, 330(2):156.
  • 7Mclarthy CJ,Crofford LJ,Greensen J,et al.Cyclooxygenase-2 expression in gastricantral mucosa before and after eradication of Helicobacter pylori infection[J].Am J Gastroenterol, 1999,94:1218.
  • 8KONTUKEK P C,HARTWICH A,ZUCHOWICZ M,et al.Helicobacter pylori,gastrin and cyclooxygenases in gastric cancer[J].J PhysiolPharmacol,2000,51(4):737.
  • 9Moalic S,Liagre B,Le Ball JC.Dose dependent modulation of apoptosis and cyclooxygenase-2 expression in human I 547 osteosarcoma cells by NS-398 a selective cydooxygenase-2 inhibitor[J].Intemational journal of oncology ,2001,18(3):533.
  • 10Jacoby RF, Cole CE,Tutsch K,et al.Chemopreventive efficacy of combiped piroxieam and flu orome thylomithine treatment of Ape mutant Min mouse adenomas and selective toxicity against Ape mutant embryos[J].Cancer Res,2000,60.

引证文献6

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部